CRX.L Regulatory News (CRX)

7 Jun 2005 07:01

Cyprotex PLC07 June 2005 Press Release 7 June 2005 Cyprotex Plc ("Cyprotex" or "the Company") Issue of 76,042 shares pursuant exercise of options Cyprotex PLC (AIM: CRX), the provider of pharmacokinetic technology andinformation, today announces that it has issued 76,042 new ordinary shares of 1peach ("new Ordinary Shares") pursuant to the exercise of options. The issue of the new Ordinary Shares is subject to the new Ordinary Shares beingadmitted to trading on AIM, application for which will be made. Trading in thenew Ordinary Shares, which will rank pari passu in all respects with theexisting ordinary shares, is expected to commence on 13 June 2005. - Ends - For further information:Cyprotex PLCRobert Morrisson Atwater, Tel: +44 (0) 1625 505 152 Chairman & Chief Executive Officerir@cyprotex.com www.cyprotex.com Code SecuritiesCharles Walker Tel: +44 (0) 20 7024 2000cew@codesecurities.com www.codesecurities.com Media enquiries:Abchurch CommunicationsHeather Salmond / Tania Wild Tel: +44 (0) 20 7398 7700 heather.salmond@abchurch-group.com www.abchurch-group.com This information is provided by RNS The company news service from the London Stock Exchange